“Conjunctivitis Does Not Increase With Longer Duration of Lebrikizumab Exposure in Patients With Moderate-to-Severe Atopic Dermatitis”. SKIN The Journal of Cutaneous Medicine 7, no. 6 (November 13, 2023): s276. Accessed April 18, 2026. https://skin.dermsquared.com/skin/article/view/2386.